Resveratrol-d4

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Pirola L, et al. Resveratrol: one molecule, many targets. IUBMB Life. 2008 May;60 (5) :323-32.|[3]Lu R, et al. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol. 1999 Jun;179 (3) :297-304.|[4]Lee MH, et al. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res. 2009 Sep 15;69 (18) :7449-58.|[5]Du LL, et al. Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi. Age (Dordr) . 2014 Apr;36 (2) :613-23.|[6]Smutny T, et al. Resveratrol as an inhibitor of pregnane X receptor (PXR) : another lesson in PXR antagonism. J Pharmacol Sci. 2014;126 (2) :177-8.|[7]Eun Nim Kim, et al. Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging (Albany NY) . 2018 Jan; 10 (1) : 83–99.|[8]Huige Li, et al. Resveratrol and Vascular Function. Int J Mol Sci. 2019 Apr 30;20 (9) :2155.